FindTrial
Sign In

Effects of serum 1,5-AG level on the occurrence of contrast-induced acute kidney injury and long-term prognosis in patients undergoing percutaneous coronary intervention

Effects of serum 1,5-AG level on the occurrence of contrast-induced acute kidney injury and long-term prognosis in patients undergoing percutaneous coronary intervention

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100045684
Enrollment
Unknown
Registered
2021-04-23
Start date
2021-05-01
Completion date
Unknown
Last updated
2021-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

contrast-induced acute kidney injury

Interventions

Case series:no

Sponsors

Department of Cardiology, Zhongda Hospital of Southeast University Medical School
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed as coronary artery disease; 2. Aged 18 to 80 years; 3. PTCA or stent implantation.

Exclusion criteria

Exclusion criteria: 1. End-stage renal disease requiring dialysis; 2. Known allergy to contrast agent; 3. Intravascular administration of contrast medium within 7 days; 4. Combined with other diseases: autoimmune diseases, hepatic insufficiency, malignant tumor, or hematology disease.

Design outcomes

Primary

MeasureTime frame
Contrast Media Nephropathy Incidence;—

Countries

China

Contacts

Public ContactYan Gaoliang

Department of Cardiology, Zhongda Hospital of Southeast University Medical School

yanshipingguo@163.com+86 18761890380

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026